 We have been an early investor in all 19. Now, we've invested in some that didn't make it, but we are the only ones, one of the very few, that invest in very early stage because there's no payback for that. We do it because it's the right thing to do so that we can get these drugs out there so that people can have the drugs that can help them either stay disease-free